Long Term Portfolio
Long-Term Portfolio
| Ticker | First Mention | My Entry | Last | P/L % | Market Cap |
|---|---|---|---|---|---|
| CGTX | — | — | — | — | —— |
| ALGS | — | — | — | — | —— |
| SPRO | — | — | — | — | —— |
| SLDB | — | — | — | — | —— |
EOD and Market cap from publicly available data.
Updates:
SPRO: 14th Nov, added some $2.50 call for Apr 26' @$0.50
SLDB: Q3 Earnings on 3rd of November disappointed many with the delay to the anticipated FDA meeting, however, the interim results of SGT-003 looks solid and will continue to hold into minimum mid 2026.
ALGS: long hold until minimum 2026 YE and beyond, averaged down further from $9.09 with early November dip. Latest HC Wainwright Liver Disease presentation and Q-10 filing shows an interesting shift in MASH strategy, as the company is pushing towards synergetic benefit with incretin receptor agonists for the improved outcome in the weight-loss (Ozempic and Mounjaro and alike), with additional preclinical data to be released to prove the claim.
14th Nov. Update, took 28% loss at $6.05, then used the money to profit from scalping CDTX then rebought ALGS $6.32 and increasing number of shares by about 20%.
Watchlist
| Ticker | First Mention | Entry | Exit | Latest Price | P/L % |
|---|---|---|---|---|---|
| LTRN | — | — | — | — | — |
| IVA | — | — | — | — | — |
EOD prices from publicly available data. P/L calculated from Entry to Exit price.
Remarks
LTRN: Took profit at $4.50 and waiting for re-entry since the expected results weren't published in September, and an offering might be imminent.
IVA: Took profit at $7.85 and waiting for re-entry as the price gap between the French Exchange and NASDAQ were unsustainable. Detailed information here
$ALGS, over 5000% potential with Best-in-class HBV & MASH candidates with strong data. The most complete independent report available for this company - Long read
by u/oquido in pennystocks
Why $SPRO Might Be One of the Safest Undervalued Biotech Plays: Backed by GSK
by u/oquido in pennystocks
$LTRN, an oncology biotech with AI potential
by u/oquido in pennystocks
Disclaimer
The information provided on this website is for informational purposes only and should not be construed as
financial, investment, legal, or professional advice. While efforts are made to ensure accuracy, no guarantee
is given regarding completeness or reliability. Visitors should conduct their own research or consult a qualified
advisor before making any decisions. External links are provided for convenience and do not imply endorsement.